Mometasone Furoate Sandoz Ltd

Mometasone furoate, the active ingredient in Mometasone Furoate Sandoz Ltd, is a corticosteroid presented as a topical formulation for skin application. It is used to reduce inflammation and relieve symptoms in various dermatologic conditions such as psoriasis, eczema and allergic skin reactions in adults and children.

GNH USA supplies Mometasone Furoate Sandoz Ltd as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mometasone furoate is a topical corticosteroid used to manage inflammatory skin disorders.

- Psoriasis: reduces scaling, erythema and plaque thickness. - Eczema: alleviates itching, redness and swelling. - Atopic dermatitis: controls flare‑ups and improves skin barrier function. - Allergic skin reactions: diminishes inflammation and hives caused by allergens.

Mometasone furoate may cause local and systemic adverse reactions when applied to the skin.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or peeling of the treated skin. - Erythema or mild redness. - Folliculitis or acneiform eruptions. - Telangiectasia with prolonged use.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Striae (stretch marks) formation. - Secondary bacterial, fungal or viral skin infections. - Hypersensitivity reactions such as contact dermatitis. - Systemic effects like adrenal suppression with extensive application. - Delayed wound healing or ulceration.

Before using Mometasone furoate, consider the following safety measures.

- Application area: limit use to affected skin only and avoid large surface areas. - Duration of therapy: use for the shortest effective period to minimize skin atrophy. - Concomitant infections: do not apply on active bacterial, fungal or viral skin infections. - Age restrictions: avoid use on infants unless specifically prescribed. - Occlusive dressings: avoid covering treated skin with airtight dressings unless directed. - Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Mometasone furoate can interact with other agents that affect skin integrity or systemic corticosteroid levels.

Major Interactions (Avoid):\n- Systemic corticosteroids: may increase risk of systemic side effects such as adrenal suppression. - Antifungal or antibacterial topicals: concurrent use may mask signs of infection.

Moderate Interactions (Monitor Closely): - Skin‑lightening agents (e.g., hydroquinone): may increase irritation. - Retinoids (topical or oral): may exacerbate skin thinning. - Immunosuppressants: monitor for heightened infection risk.